• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is closed. Thank you to everyone who submitted a nomination.

Primary Sidebar

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Len Johnrose, England

    Len Johnrose, England

  • John Dinon, Australia

    John Dinon, Australia

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Michael Lee, Australia

    Michael Lee, Australia

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Ali Var, Turkey

    Ali Var, Turkey

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Ali Var, Turkey

    Ali Var, Turkey

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Paul Launer, USA

    Paul Launer, USA

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • David Solomon, UK

    David Solomon, UK

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Jay Epstein, USA

    Jay Epstein, USA

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login